Common Contracts
3 similar Development and License Agreement contracts by Pfenex Inc.
EX-10.35 4 d904589dex1035.htm EX-10.35 CONFIDENTIAL TREATMENT REQUESTEDDevelopment and License Agreement • May 5th, 2020 • New York
CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. INFORMATION THAT WAS OMITTED IN THE EDGAR VERSION HAS BEEN NOTED IN THIS DOCUMENT WITH A PLACEHOLDER IDENTIFIED BY THE MARK “[***].”
DEVELOPMENT AND LICENSE AGREEMENT by and between PFENEX INC. and HOSPIRA BAHAMAS BIOLOGICS LTD. February 9, 2015Development and License Agreement • April 23rd, 2015 • Pfenex Inc. • Pharmaceutical preparations • New York
This DEVELOPMENT AND LICENSE AGREEMENT (this “Agreement”) is entered into as of February 9, 2015 (the “Signature Date”) by and between Pfenex Inc., a Delaware corporation (“Pfenex”), and Hospira Bahamas Biologics Ltd., a company incorporated under the laws of the Bahamas (“Hospira”).
DEVELOPMENT AND LICENSE AGREEMENT by and between PFENEX INC. and HOSPIRA BAHAMAS BIOLOGICS LTD. February 9, 2015Development and License Agreement • April 15th, 2015 • Pfenex Inc. • Pharmaceutical preparations • New York
This DEVELOPMENT AND LICENSE AGREEMENT (this “Agreement”) is entered into as of February 9, 2015 (the “Signature Date”) by and between Pfenex Inc., a Delaware corporation (“Pfenex”), and Hospira Bahamas Biologics Ltd., a company incorporated under the laws of the Bahamas (“Hospira”).
